A BLOOD group has been shown to significantly influence the chance that prostate cancer will return after successful surgery.
Men with group O blood are far less likely to suffer a recurrence of the disease following surgical intervention. By contrast, men with blood group A were shown by new research to be 35 per cent more likely to fall victim to the disease again – even after surgery.
Prostate cancer is the most common form of cancer in European men and 40,000 cases are diagnosed in Britain annually.